Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Canadian Multi-arm Multi-stage Randomized Controlled Trial Assessing Front Line and Maintenance Treatment in Serous or p53 Mutant Endometrial Cancer

NCT04159155 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT04159155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04159155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Canadian Multi-arm Multi-stage Randomized Controlled Trial Assessing Front Line and Maintenance Treatment in Serous or p53 Mutant Endometrial Cancer
Lead sponsor
University Health Network, Toronto
Phase
Phase 2/3
Overall status
Terminated
Start date
November 17, 2020
Completion date
May 26, 2025
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial carcinoma, p53 mutation, serous carcinoma